Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease

NeuroRehabilitation

Volumn 23, Issue 5, 2008, Pages 425-438

  Zec, Ronald F ^a   Burkett, Nicole R ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Pharmacological and behavioral treatment; Risk factors

Indexed keywords

ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ASCORBIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DONEPEZIL; GALANTAMINE; HYPNOTIC AGENT; MEMANTINE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; ROFECOXIB; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACRINE; THIAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

AGITATION; ALZHEIMER DISEASE; ANOREXIA; ANXIETY DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DELUSION; DEPRESSION; DIARRHEA; DRIVING ABILITY; DRIVING IMPAIRMENT; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; GAIT DISORDER; HALLUCINATION; HUMAN; INCONTINENCE; MOTOR DYSFUNCTION; NAUSEA; PHYSICAL DISABILITY; PROTECTION; REVIEW; RISK FACTOR; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYMPTOM; URINARY TRACT INFECTION; VOMITING; WEIGHT GAIN;

EID: 55549083841     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2008-23506     Document Type: Review

References (79)

1. R.D. Abbott, L.R. White, G.W. Ross, K.H. Masaki, J.D. Curb and H. Petrovitch, Walking and dementia in physically capable elderly men, Journal of the American Medical Association 292(12) (2004), 1447-1453.
2. P.A. Adlard, V.M. Perreau, V. Pop and C.W. Cotman, Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease, Journal of Neuroscience 25(17) (2005), 4217-4221.
3. N.C. Berchtold, G. Chinn, M. Chou, J.P. Kesslak and C.W. Cotman, Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus, Neuroscience 133(3) (2005), 853-861.
4. C.M. Callahan, M.A. Boustani, F.W. Unverzagt, M.G. Austrom, T.M. Damush, A.J. Perkins, B.A. Fultz, S.L. Hui, S.R. Counsell and H.C. Hendrie. Effectiveness of Collaborative Care for Older Adults with Alzheimer Disease in Primary Care: A Randomized Controlled Trial, Journal of the American Medical Association 295 (2006), 2148-2157.
5. D.B. Carr, Motor vehicle crashes and drivers with DAT, Alzheimer Disease and Associated Disorders 11(Suppl 10) (1997), 38-41.
6. D.B. Carr, J.M. Duchek, T.M. Meuser and J.C. Morris, Older adult drivers with cognitive impairment, American Family Physician 73(6) (2006), 1029-1034.
7. D.B. Carr, J. Duchek and J.C. Morris, Characteristics of motor vehicle crashes of drivers with dementia of the Alzheimer type, Journal of the American Geriatrics Society 48(1) (2000), 18-22.
8. R.K. Chandra, Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects, Nutrition 17(9) (2001), 709-712.
9. C. Courtney, D. Farrell, R. Gray, R. Hills, L. Lynch, E. Sellwood, S. Edwards, W. Hardyman, J. Raftery, P. Crome, C. Lendon, H. Shaw and P. Bentham, AD2000 Collaborative Group, Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial, Lancet 363(9427) (2004), 2105-2115.
10. J.L. Cummings, Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations, American Journal of Geriatric Psychiatry 11(2) (2003b), 131-145.
11. R.S. Doody, J.C. Stevens, C. Beck, R.M. Dubinsky, J.A. Kaye, L. Gwyther, R.C. Mohs, L.J. Thal, P.J. Whitehouse, S.T. DeKosky and J.L. Cummings, Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology 56(9) (2001), 1154-1166.
12. D.A. Drachman and J.M. Swearer, Driving and Alzheimer's disease: the risk of crashes, Neurology 43(12) (1993), 2448-2456.
13. R. M. Dubinsky, A.C. Stein and K. Lyons, Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology, Neurology 54(12) (2000), 2205-2211.
14. J.M. Duchek, D.B., Carr, L. Hunt, C.M. Roe, C. Xiong, K. Shah and J.C. Morris, Longitudinal driving performance in early-stage dementia of the Alzheimer type, Journal of the American Geriatric Society 51(10) (2003), 1342-1347.
15. H. Feldman, S. Gauthier, J. Hecker et al., Efficacy of donepezil in early-stage Alzheimer disease, Neurology 61 (2004), 1852-1856.
16. D.C. Grabowski, C.M. Campbell and M.A. Morrisey, Elderly licensure laws and motor vehicle fatalities, Journal of the American Medical Association 291(23) (2004), 2840-2846.
17. L.A. Hunt, C.F. Murphy, D. Carr, J.M. Duchek, V. Buckles and J.C. Morris, Environmental cueing may affect performance on a road test for drivers with dementia of the Alzheimer type, Alzheimer Disease and Associated Disorders 11(Suppl 1) (1997), 13-16.
18. L.A. Hunt, C.F. Murphy, D. Carr, J.M. Duchek, V. Buckles and J.C. Morris, Reliability of the Washington University Road Test, A performance-based assessment for drivers with dementia of the Alzheimer type, Archives of Neurology 54(6) (1997), 707-712.
19. T. Ikeda, K. Yamamoto, K. Takahashi, Y. Kaku, M. Uchiyama, K. Sugiyama and M.Yamada, Treatment of Alzheimer-type dementia with intravenous mecobalamin, Clinical Therapeutics 14(3) (1992), 426-437.
20. J.H. Kang, A. Ascherio, F. Grodstein, Fruit and vegetable consumption and cognitive decline in aging women, Annals of Neurology 57(5) (2005), 713-720.
21. E.B. Larson, L. Wang, J.D. Bowen, W.C. McCormick, L. Teri, P. Crane and W. Kukull,Exercise is associated with reduced risk for incident dementia among persons 65 years ofage and older, Annals of Internal Medicine 144(2) (2006), 73-81.
22. R.G. Logsdon and L. Teri, The Pleasant Events Schedule-AD: psychometric properties andrelationship to depression and cognition in Alzheimer's disease patients, Gerontologist 37(1) (1997), 40-45.
23. R.G. Logsdon, L. Teri and E.B. Larson, Driving and Alzheimer's disease, Journal of General Internal Medicine 7(6) (1992), 583-588.
24. J.A. Luchsinger, J.M. Noble and N. Scarmeas, Diet and Alzheimer's disease, Current Neurology and Neuroscience Reports 7(5) (2007), 366-372.
25. C. Lundberg, K. Johansson, K. Ball, B. Bjerre, C. Blomqvist, A. Braekhus, W.H. Brouwer, F.W. Bylsma, D.B. Carr, L. Englund, R.P. Friedland, L. Hakamies-Blomqvist, G. Klemetz, D.O'Neill, G.L. Odenheimer, M. Rizzo, M. Schelin, M. Seideman, K. Tallman, M. Viitanen, P.F. Waller and B. Winblad, Dementia and driving: an attempt at consensus, Alzheimer Disease and Associated Disorders 11(1) (1997), 28-37.
26. C.G. Lyketsos, L. DelCampo, M. Steinberg, Q. Miles, C.D. Steele, C. Munro, A.S. Baker, J.M. Sheppard, C. Frangakis, J. Brandt and P.V. Rabins, Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS, Archives of General Psychiatry 60(7) (2003), 737-746.
27. K.H. Masaki, K.G. Losonczy, G. Izmirlian, D.J. Foley, G.W. Ross, H. Petrovitch, R. Havlik and L.R. White, Association of vitamin E and C supplement use with cognitive function anddementia in elderly men, Neurology 54(6) (2000), 1265-1272.
28. S.M. McCurry, L.E. Gibbons, R.G. Logsdon, M. Vitiello and L. Teri, Training caregivers tochange the sleep hygiene practices of patients with dementia: the NITE-AD project, Journal of the American Geriatric Society 51(10) (2003), 1455-1460.
29. S.M. McCurry, R.G. Logsdon, L. Teri, L.E. Gibbons, W.A. Kukull, J.D. Bowen, W.C. McCormick and E.B. Larson, Characteristics of sleep disturbance in communitydwellingAlzheimer's disease patients, Journal of Geriatric Psychiatry and Neurology 12(2) (1999), 53-59.
30. S.M. McCurry, R.G. Logsdon, M.V. Vitiello and L. Teri, Successful behavioral treatment for reported sleep problems in elderly caregivers of dementia patients: a controlled study, The Journals of Gerontology, Series B, Psychological Sciences and Social Sciences 53(2) (1998), 122-129.
31. S.M. McCurry, C.F. Reynolds, S. Ancoli-Israel, L. Teri and M.V. Vitiello, Treatment of sleep disturbance in Alzheimer's disease, Sleep Medicine Reviews 4(6) (2000), 603-628.
32. M.S. Mega, J.L. Cummings, T. Fiorello and J. Gornbein, The spectrum of behavioral changes in Alzheimer's disease, Neurology 46(1) (1996), 130-135.
33. W. Meins, T. Muller-Thomsen and H.P. Meier-Baumgartner, Subnormal serum vitamin B12 and behavioural and psychological symptoms in Alzheimer's disease, International Journal of Geriatric Psychiatry 15(5) (2000), 415-418.
34. C. Merchant, M.X. Tang, S. Albert, J. Manly, Y. Stern and R. Mayeux, The influenceof smoking on the risk of Alzheimer's disease, Neurology 52(7) (1999), 1408-1412.
35. E.R. Miller, R. Pastor-Barriuso, D. Dalal, RA Riemersma, L.J. Appel and E. Guallar, Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality, Annals of Internal Medicine 142(1) (2005), 37-46.
36. J.C. Morris, Dementia update 2005, Alzheimer Disease and Associated Disorders 19(2) (2005), 100-117.
37. M.C. Morris, L.A. Beckett, P.A. Scherr, L.E. Hebert, D.A. Bennett, T.S. Field and D.A. Evans, Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease, Alzheimer Disease and Associated Disorders 12(3) (1998), 121-126.
38. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, J. Schneiderand R.S. Wilson, Dietary fats and the risk of incident Alzheimer disease, Archives of Neurology 60(2) (2003),194-200.
39. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, R.S.Wilson and P.A. Scherr, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study, Journal of the American Medical Association 287(24) (2002), 3230-3237.
40. J.T. Olin, L.S. Schneider, I.R. Katz, B.S. Meyers, G.S. Alexopoulos, J.C. Breitner, M.L. Bruce, E.D. Caine, J.L. Cummings, D.P. Devanand, K.R. Krishnan, C.G. Lyketsos, J.M. Lyness, P.V. Rabins, C.F. Reynolds 3rd, B.W. Rovner, D.C. Steffens, P.N. Tariot and B.D. Lebowitz, Provisional diagnostic criteria for depression of Alzheimer disease, American Journal of Geriatric Psychiatry 10(2) (2002a), 125-128.
41. J.T. Olin, I.R. Katz, B.S. Meyers, L.S. Schneider and B.D. Lebowitz, Provisional diagnosticcriteria for depression of Alzheimer disease: rationale and background, American Journal of Geriatric Psychiatry 10(2) (2002b), 129-141.
42. N.V. Patel, M.N. Gordon, K.E. Connor, R.A. Good, R.W. Engelman, J. Mason, D.G. Morgan, T.E. Morgan and C.E. Finch, Caloric restriction attenuates Abeta-deposition inAlzheimer transgenic models, Neurobiology of Aging 26(7) (2005), 995-1000.
43. R.C. Petersen, R.G. Thomas, M. Grundman, D. Bennett, R. Doody, S. Ferris, D. Galasko, S. Jin, J. Kaye, A. Levey, E. Pfeiffer, M. Sano, C.H. van Dyck and L.J. Thal, Alzheimer's DiseaseCooperative Study Group, Vitamin E and donepezil for the treatment of mild cognitive impairment, New England Journal of Medicine 352(23) (2005), 2379-2388.
44. V.L. Phillips and S. Diwan, The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people, Journal of the American Geriatric Society 51(2) (2003), 188-193.
45. L.J. Podewils, E. Guallar, K.H. Kuller, L.P. Fried, O.L. Lopez, M. Carlson and C.G. Lyketsos, Physical activity, APOE genotype and dementia risk: findings from the Cardiovascular Health Cognition Study, American Journal of Epidemiology 161(7) (2005), 639-651.
46. M.A. Raskind, E.R. Peskind, L. Truyen, P. Kershaw and C.V. Damaraju, The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial, Archives of Neurology 61(2) (2004), 252-256.
47. M. Rizzo, D.V. McGehee, J.D. Dawson and S.N. Anderson, Simulated car crashes at intersections in drivers with Alzheimer disease, Alzheimer Disease and Associated Disorders 15(1) (2001), 10-20.
48. K. Rockwood, Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease, Journal of Neurology, Neurosurgery and Psychiatry 75(5) (2004), 677-685.
49. J.L. Rodriguez-Martin, J.M. Lopez-Arrieta and N. Qizilbash, Thiamine for Alzheimer'sdisease, Cochrane Database of Systematic Reviews 2 (2000), CD001498.
50. S. Salloway, S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar and S. Richardson, Donepezil 401 Study Group, Efficacy of donepezil in mild cognitive impairment: a randomizedplacebo-controlled trial, Neurology 63(4) (2004), 651-657.
51. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, New England Journal of Medicine 336(17) (1997), 1216-1222.
52. M. Sano, Economic effect of cholinesterase inhibitor therapy: implications for managed care, Managed Care Interface 17(8) (2004), 44-49.
53. P.S. Santaguida, P. Raina, L. Booker, C. Patterson, F. Baldassarre, D. Cowan, M. Gauld, M. Levine and A. Unsal, Pharmacological Treatment of Dementia. Evidence Report/ Technology Assessment No. 97 (Prepared by McMaster University Evidence-based Practice Center under Contract No. 290-02-0020), AHRQ Publication No. 04-E018-2. Rockville, MD: Agency for Healthcare Research and Quality, 2004.
54. N. Scarmeas, Y. Stern, R. Mayeux and J.A. Luchsinger, Mediterranean diet, Alzheimer disease and vascular mediation, Archives of Neurology 63 (2006), 1709-1717.
55. N. Scarmeas, Y. Stern, M.X. Tang, R. Mayeux and J.A. Luchsinger, Mediterranean diet and risk for Alzheimer's disease, Annals of Neurology 59 (2006), 912-921.
56. L.S. Schneider, K. Dagerman and P.S. Insel, Efficacy and adverse effects of atypicalantipsychotics for dementia: metaanalysis of randomized, placebo-controlled trials, American Journal of Geriatric Psychiatry 14 (2006), 191-210.
57. L.S. Schneider, P.N. Tariot, K.S. Dagerman, S.M. Davis, J.K. Hsiao, M.S. Ismail, B.D.Lebowitz, C.G. Lyketsos, J.M. Ryan, T.S. Stroup, D.L. Sultzer, D. Weintraub and J.A. Lieberman, CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs inpatients with Alzheimer's disease, New England Journal of Medicine 355 (15) (2006), 1525-1538.
58. B. Seltzer, P. Zolnouni, M. Nunez, R.Goldman, D. Kumar, J. Ieni and S. Richardson, Donepezil "402" Study Group, Efficacy of donepezil in early-stage Alzheimer disease: arandomized placebo-controlled trial, Archives of Neurology 61(12)(2004), 1852-1856.
59. K.M. Sink, K.F. Holden and K. Yaffe, Pharmacological treatment of neuropsychiatricsymptoms of dementia: a review of the evidence, Journal of the American Medical Association 293(5) (2005), 596-608.
60. P.N. Tariot, M.R. Farlow, G.T. Grossberg, S.M. Graham, S. McDonald, I. Gergel and Memantine Study Group, Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial, Journal of the American Medical Association 291(3) (2004), 317-324.
61. B.D. Taylor and S. Tripodes, The effects of driving cessation on the elderly withdementia and their caregivers, Accident, Analysis and Prevention 33 (2001), 519-528.
62. L. Teri, Behavioral treatment of depression in patients with dementia, Alzheimer Disease and Associated Disorders 8 (Suppl 3) (1994), 66-74.
63. L. Teri, Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver distress, Alzheimer Disease and Associated Disorders 11 (Suppl 4) (1997), 35-38.
64. L. Teri and D. Gallagher-Thompson, Cognitive-behavioral interventions for treatment ofdepression in Alzheimer's patients, Gerontologist 31(3) (1991), 413-416.
65. L. Teri, L.E. Gibbons, S.M. McCurry, R.G. Logsdon, D.M. Buchner, W.E. Barlow, W.A.Kukull, A.Z. LaCroix, W. McCormick and E.B. Larson, Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial, The Journal of the American Medical Association 290(15) (2003), 2015-2022.
66. L. Teri, E.B. Larson and B.V. Reifler, Behavioral disturbance in dementia of the Alzheimer's type, Journal of the American Geriatric Society 36(1) (1988), 1-6.
67. L. Teri and R. Logsdon, Assessment and management of behavioral disturbances in Alzheimer's disease, Comprehensive Therapy 16(5) (1990), 36-42.
68. L. Teri and R.G. Logsdon, Identifying pleasant activities for Alzheimer's diseasepatients: the pleasant events schedule-AD, Gerontologist 31(1) (1991), 124-127.
69. L. Teri, R.G. Logsdon and S.M. McCurry, Nonpharmacologic treatment of behavioraldisturbance in dementia, The Medical Clinics of North America 86(3) (2002), 641-656.
70. L. Teri, R.G. Logsdon, J. Uomoto and S.M. McCurry, Behavioral treatment of depression indementia patients: a controlled clinical trial, The Journals of Gerontology, Series B, Psychological Sciences and Social Sciences 52(4) (1997), 159-166.
71. L. Teri, P. Rabins, P. Whitehouse, L. Berg, B. Reisberg, T. Sunderland, B. Eichelman and C. Phelps, Management of behavior disturbance in Alzheimer disease: current knowledgeand future directions, Alzheimer Disease and Associated Disorders 6(2) (1992), 77-88.
72. L. Teri and A. Wagner, Alzheimer's disease and depression, Journal of Consulting and Clinical Psychology 60(3) (1992), 379-391.
73. L.J. Thal, S.H. Ferris, L. Kirby, G.A. Block, C.R. Lines, E. Yuen, C. Assaid, M.L. Nessly, B.A. Norman, C.C. Baranak and S.A. Reines, Rofecoxib Protocol 078 study group, A randomized,double-blind, study of rofecoxib in patients with mild cognitive impairment, Neuropsychopharmacology 30(6) (2005), 1204-1215.
74. R.E. Tractenberg, C.M. Singer, J.L. Cummings and L.J. Thal, The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease, Journal of Sleep Research 12(4) (2003), 331-337.
75. A.H. van Zomeren, W.H. Brouwer and J.M. Minderhoud, Acquired brain damage anddriving: a review, Archives of Physical Medicine and Rehabilitation 68(10) (1987), 697-705.
76. P.P.Vitaliano, J. Russo, H.M. Young, L. Teri and R.D. Maiuro, Predictors of burden in spouse caregivers of individuals with Alzheimer's disease, Psychology of Aging 6(3) (1991), 392-402.
77. J. Wang, L. Ho, W. Qin, A.B. Rocher, I. Seror, N. Humala, K. Maniar, G. Dolios, R. Wang, P.R. Hof and G.M. Pasinetti, Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB Journal 19(6) (2005), 659-661.
78. M.F. Weiner and L. Teri, Psychological and Behavioral Management, in: The Dementias: Diagnosis, Treatment and Research, M.F. Weiner and A.M. Lipton, eds, AmericanPsychiatric Publishing, Inc., Washington, D.C., 2003, pp. 181-218.
79. G.S. Zubenko, W.N. Zubenko, S. McPherson, E. Spoor, D.B. Marin, M.R. Farlow, G.E. Smith, Y.E. Geda, J.L. Cummings, R.C. Petersen and T. Sunderland, A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease, American Journal of Psychiatry 160(5) (2003), 857-866.